AstraZeneca’s first foray with PD-L1 inhibitor Imfinzi as a treatment for bladder cancer was a flop. | Following an FDA ...

(Reuters) -Gilead Sciences' Trodelvy failed to improve survival for patients with advanced bladder cancer and only modestly extended the lives of previously treated patients with late-stage lung ...

Over the decades, scientists have revealed many strategies that keep normal cells from becoming cancerous. Understanding natural anti-tumor processes could help researchers develop better approaches ...

In May, surgeons at the University of Southern California and the University of California, Los Angeles, collaborated to perform the world's first human bladder transplant. Currently, when a bladder ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The drug is approved for breast ...

In May, surgeons at USC and UCLA collaborated to perform the world’s first-in-human bladder transplant. Currently, when a bladder fails or needs to be removed, doctors create a “neobladder” using a ...

Sanofi Pasteur said it’s discontinuing the manufacture of TheraCys, an important bladder cancer drug, and shortages are expected, while the US Food and Drug Administration (FDA) on Friday released ...